Change in Executive Leadership at CHDR: Koos Burggraaf Steps Down as CEO, Anouk de Jong Assumes CFO Role, Geert Jan Groeneveld Appointed New CEO
Leiden, the Netherlands 19 February 2024 - The Supervisory Board of CHDR (Centre for Human Drug Research) announces a transition in its executive leadership team. Koos Burggraaf, who has served as CEO for 6 years, will be stepping down from his current position. However, he will continue his journey with CHDR by spearheading the establishment of the CHDR Academy. In this new capacity, Koos will focus on (post-academic) education, provide research support, and maintain his involvement as a mentor for PhD candidates.
The transition also includes the appointment of Anouk de Jong as the Chief Financial Officer (CFO) and Geert Jan Groeneveld as the new Chief Executive Officer (CEO) of CHDR. Anouk brings a wealth of financial expertise and strategic insight to her new role. Geert Jan, with his extensive experience and leadership acumen, is prepared to lead CHDR into its next phase of growth and innovation.
The Supervisory Board expresses its gratitude to Koos for his remarkable contributions to CHDR. Under his guidance, the organization has experienced significant development and growth, demonstrating resilience particularly throughout the challenges posed by the COVID-19 pandemic. Koos' dedication and vision have been instrumental in positioning CHDR as a leading institution in human drug research.
"We are immensely thankful to Koos for his outstanding leadership and commitment to CHDR," said W. Spaan, Chair of the Supervisory Board. "His passion for advancing human drug research has been truly inspirational, and we are confident that his new role within the CHDR Academy will further enrich our endeavors."
The Board looks forward to the continued success of CHDR under the leadership of Anouk de Jong and Geert Jan Groeneveld. Their combined expertise and strategic vision will undoubtedly propel CHDR to new heights, ensuring its continued impact in the field of human drug research.
